Meeting Real-World Challenges in Cardiovascular Disease Risk Management: A Pan-European Crowdsourcing Activity
Join the Crowd
Join your colleagues from across Europe in providing unique insight into the management of ASCVD prevention.
Take Survey Now
- Overview
- Steering Committee
Overview
Meeting Real-World Challenges in Cardiovascular Disease Risk Management: A Pan-European Crowdsourcing Activity
You will appreciate the important role clinical guidelines play in the practice of medicine. However, current guidelines often prove difficult to implement in day-to-day practice. For cardiovascular disease (CVD) prevention, major risk factors remain undertreated1,2, and despite major advances in non-statin pharmacological approaches, patient outcomes have not been improved along the same trajectory. This implies that newer and more effective agents are currently underutilised. In order to understand the main barriers precluding the optimal use of these agents, we are seeking input from both primary and secondary care healthcare professionals who manage those at increased CVD risk, to identify how to foster a coordinated response to diagnosing and managing patients according to their risk profile3,4.
To achieve this, Radcliffe Medical Education is taking a novel crowdsourcing approach to pool the insight and practices of physicians from across Europe – the findings of which will be presented in a CME-accredited webinar and form the basis of future educational interventions aimed at mobilising more effective management.
To help shape this we are looking to recruit a broad spectrum of prescribers from Europe to complete this survey. Interested participants should:
- currently manage patients with hypercholesterolemia
- be able to prescribe statin and non-statin therapy
Take Survey Now
If you have colleagues also managing individuals with or at risk of ASCVD who you consider to have a good understanding of lipid-lowering therapy and whose opinion you regard as valuable, and whom you think would be interested in taking part in this research project please click here.
Invite colleagues
References
1. Nicholls S, et al. Eur Cardiol. 2018 Aug; 13(1): 9–13
2. Viarani S, et al. Circ Cardiovasc Qual Outcomes. 2018 May;11(5)
3. Mach F, et al. Eur Heart J. Volume 41, Issue 1, 1 Jan; 2020: 111–188
4. Packard C, et al. Heart. 2021 Feb; 0: 1–7.
This research has been made possible by an unrestricted educational grant from Novartis and is endorsed by the International Society of Cardiovascular Pharmacotherapy (ISCP). Radcliffe Medical Education have provided content, organisational and logistical support.
Steering Committee
To execute this exciting project, the Steering Committee of leading, global experts in CVD prevention, will develop high-quality educational material based on the unique insight from our survey.
Executive Steering Committee
Professor Kausik Ray
Chair
Professor of Public Health, Deputy Director of Imperial Clinical Trials Unit and Head of Commercial Trials within the Department of Public Health and Primary Care, School of Public Health, Imperial College London, UK.
President of the European Atherosclerosis Society (EAS).
Dr Carlos Aguiar
Committee Member
Consultant Cardiologist at the Hospital Santa Cruz in Lisbon, Portugal.
Professor Maciej Banach
Committee Member
Secretary of the European Atherosclerosis Society (EAS)
President, International Lipid Expert Panel (ILEP)
President, Polish Lipid Association (PoLA)
Founder, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
Editor-in-Chief, Archives of Medical Science (AMS) (IF2020=3.318)
Deputy Editor, European Heart Journal Open (EHJ-Open)
Head, Department of Preventive Cardiology and Lipidology, MUL, Lodz, Poland
Head, Cardiovascular Research Center, University of Zielona Góra, Poland
Dr Julia Brandts
Committee Member
Resident in Cardiology at the University Hospital RWTH Aachen.
Honorary Research Associate at the Imperial Centre for Cardiovascular Disease Prevention at the School of Public Health, Imperial College London.
Dr Yassir Javaid
Committee Member
Cardiovascular and Diabetes Lead Northamptonshire CCG. RCGP Clinical Adviser for Cardiology.
Council member of the British Heart Valve Society. Editorial board member for the British Journal of Cardiology.
Professor Lale Tokgözoğlu
Committee Member
Professor of Cardiology at Hacettepe University, Ankara, Turkey.
Immediate Past President of the European Atherosclerosis Society (EAS).
Deputy Editor of the European Heart Journal.
Advisory Board
Dr Kostantinos Koskinas
Advisory Board Member
Attending Physician and Head of the Dyslipidemia Center in the Department of Cardiology at Bern University Hospital, Bern, Switzerland.
Member of the 2019 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) task force for the guidelines of the management of dyslipidaemia and the 2020-2022 ESC Committee for Clinical Practice Guidelines.
Member of the European Association of Percutaneous Cardiovascular Intervention (EAPCI) and elected nucleus member of Population Science & Public Health section of the European Association of Preventive Cardiology (EAPC).
Editorial board member of EuroIntervention, the official journal of the EAPCI
Member of the ESC Clinical Practice Guidelines (CPG) Committee.
Professor François Schiele
Advisory Board Member
Professor Of Cardiology at the University Hospital Besançon, France
Professor of Cardiology at the Faculty of Medicine of the University of Franche Comté, Besançon, France.
Dr Antonio Vallejo-Vaz
Advisory Board Member
Researcher at University of Seville and Institute of Biomedicine of Seville, Spain.
Honorary Lecturer at School of Public Health, Imperial College London, United Kingdom.
Take Survey Now
© Radcliffe Medical Education. All rights reserved.